PALISADE BIO, INC.
Ticker: 1357459
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY23 | Q1 FY23 |
|---|---|---|---|
| INCOME | |||
| Revenue | 0.50+100.0% | 0.25+0.0% | 0.25 |
| Total Income | 0.50+100.0% | 0.25+0.0% | 0.25 |
| EXPENSES | |||
| Expenditure | 12.20+338.8% | 2.78+0.0% | 2.78 |
| PROFIT | |||
| Net Profit | -10.57-351.7% | -2.34+0.0% | -2.34 |
| KEY METRICS | |||
| OPM % | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% |
| EPS | -0.05+90.7% | -0.54+93.4% | -8.13 |
Corporate Events
Board MeetingPALI
202610Jun
Board Meeting
Palisade Bio, Inc. held its 2026 Annual Meeting of Stockhold…
SEC Filing ↗